The findings of this study suggest that the PNPLA3 rs738409 polymorphism may be utilized for the early detection of the high-risk group for NAFLD and decline in the renal function, even though individuals may have a normal weight status. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.